Ypsomed Holding AG
YPSN
Pozycja w akcjach
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Cena akcji
$469.39
Kapitalizacja rynkowa
$6.17B
Zmiana (1 dzień)
1.63%
Zmiana (1 rok)
18.98%
Kraj
CH
Handel Ypsomed Holding AG (YPSN)
Kategoria
Healthcare
Marża operacyjna dla Ypsomed Holding AG (YPSN)
Marża operacyjna na dzień 2026 TTM: 0.00%
Według najnowszych raportów finansowych i ceny akcji Ypsomed Holding AG, bieżąca marża operacyjna (TTM) wynosi 0.00%. Na koniec 2026 wynosiła 0.00%.
Historia marży operacyjnej dla Ypsomed Holding AG od 2002 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2025 | 15.07% | -4.13% |
| 2024 | 15.72% | 29.06% |
| 2023 | 12.18% | 98.05% |
| 2022 | 6.15% | 167.39% |
| 2021 | 2.30% | 400.00% |
| 2020 | 0.46% | -97.15% |
| 2019 | 16.12% | 23.43% |
| 2018 | 13.06% | -7.96% |
| 2017 | 14.19% | 8.07% |
| 2016 | 13.13% | 49.37% |
| 2015 | 8.79% | 56.13% |
| 2014 | 5.63% | 184.34% |
| 2013 | 1.98% | -4.35% |
| 2012 | 2.07% | -41.69% |
| 2011 | 3.55% | -32.89% |
| 2010 | 5.29% | -52.60% |
| 2009 | 11.16% | 3.53% |
| 2008 | 10.78% | 1,183.33% |
| 2007 | 0.84% | -95.81% |
| 2006 | 20.07% | 128.33% |
| 2005 | 8.79% | -5.48% |
| 2004 | 9.30% | -10.14% |
| 2003 | 10.35% | 55.64% |
| 2002 | 6.65% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 18.91% | - |
IE
|
|
| 12.67% | - |
CN
|
|
| 0.00% | - |
CH
|
|
| 34.95% | - |
CN
|
|
| 12.88% | - |
KR
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.